Abstract
Nafamostat dimesylate {systematic name: [amino({6-[(4-{[amino(iminiumyl)methyl]amino}phenyl)carbonyloxy]naphthalen-2-yl})methylidene]azanium bis(methanesulfonate)}, C19H19N5O2 2+·2CH3O3S-, is a broad-spectrum serine protease inhibitor and has been applied clinically as an anticoagulant agent during hemodialysis and for treatment of severe acute pancreatitis (SAP). Since nafamostat contains flexible moieties, it is necessary to determine the conformation to understand the structure-Activity relationships. The divalent cation has a screw-like motif. The guanidinium group is approximately perpendicular to the naphthyl ring system, subtending a dihedral angle of 84.30 (14)°. In the crystal, the nafamostat molecules form columnar structures surrounded by a hydrophilic region.
Author supplied keywords
Cite
CITATION STYLE
Fujii, I. (2021). Crystal structure of nafamostat dimesylate. Acta Crystallographica Section E: Crystallographic Communications, 77, 999–1002. https://doi.org/10.1107/S2056989021009245
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.